Skip to content
Psych Dictionary

Written exposure therapy

(WET)

  • Therapy · Cognitive-behavioral
  • Moderate evidence
  • Published October 19, 2026
  • 12 sources
  • 4 min read

In short

Written exposure therapy (WET) is a five-session treatment for PTSD, developed by Denise Sloan and Brian Marx, in which the patient writes about the traumatic event for 30 minutes per session. Developer-led trials found it noninferior to cognitive processing therapy and prolonged exposure, with fewer dropouts.

Key facts

Tradition
Cognitive-behavioral
Developed by
Denise M. Sloan and Brian P. Marx, National Center for PTSD and Boston University
Origin
Developed from studies of expressive writing for PTSD; randomized trials published from 2012
Typical format
Five weekly individual sessions, the first about an hour and the rest about 40 to 45 minutes, each including 30 minutes of writing in session; no homework between sessions
Most researched for
Posttraumatic stress disorder in civilians, veterans and active-duty service members
Also known as
Written exposure therapy for PTSD

State of the evidence

Moderate evidence

Randomized trials found WET noninferior to cognitive processing therapy in civilians and veterans[1] and in active-duty service members[2], and to prolonged exposure in veterans[3], with significantly fewer dropouts in each. All of these trials were conducted by the developers, and the 2023 VA/DoD guideline gives WET a weak recommendation, noting possible allegiance bias[4]. In a large pragmatic primary care trial, only 31.5% of patients assigned to WET completed all sessions[5].

Evidence labels summarise the research literature; they are not recommendations. How labels are assigned

Written exposure therapy (WET) is a brief, exposure-based psychological treatment for posttraumatic stress disorder (PTSD) in which the patient writes about a traumatic event during each session. It was developed by Denise Sloan and Brian Marx and consists of five sessions without assignments between them[2][6]. It belongs among the trauma-focused therapies, but it is much shorter than the established ones: cognitive processing therapy and prolonged exposure require more sessions, and its developers present brevity and low dropout as its main advantages[3].

Development from expressive writing

The protocol grew out of a series of studies by the developers on expressive writing as a treatment for PTSD[7]. A randomized trial published in 2012 assigned 46 adults with PTSD after motor vehicle accidents to WET or a waiting list. Those treated had significantly greater reductions in PTSD severity at 6 and 18 weeks, with large between-group effects, fewer still met diagnostic criteria, gains were maintained at 30 weeks, and 9% dropped out[8]. Sloan and Marx published a treatment manual in 2019[6].

The five-session protocol

As described by its developers, WET consists of five weekly sessions, the first lasting about an hour and each later session about 45 minutes[7]. In the first session the therapist explains common reactions to trauma and the rationale for the treatment, and the patient then completes the first 30-minute writing period. In every session the therapist reads out the specific writing instructions for that session, the patient writes for 30 minutes, and the therapist stops the writing when the time is up and briefly checks the patient’s reaction[7].

The instructions change over the course of treatment. Early sessions ask for the details of the trauma together with the emotions and thoughts that occurred during it; later sessions turn toward the meaning of the event, such as what it has meant to the person and how it has changed the way they view their life. Between sessions the therapist reads the narrative to check that the instructions were followed and gives feedback on this at the start of the next session[7]. The developers report that education and IQ have not moderated outcome, since the aim is to confront the memory rather than to write well[7]. In the trial against prolonged exposure, up to two additional sessions were permitted because clinicians reported that some veterans avoided writing about the trauma in the first sessions[7][3].

Noninferiority trials against CPT and prolonged exposure

The main trials asked whether WET is no worse than a longer first-line treatment, by a prespecified margin of 10 points on the Clinician-Administered PTSD Scale for DSM-5.

In the first, 126 veterans and civilians at a Veterans Affairs facility were randomized to five sessions of WET or 12 sessions of cognitive processing therapy delivered with written accounts. Improvements with WET were noninferior at every assessment up to 36 weeks, with the largest difference, 4.31 points, at 24 weeks[1]. A follow-up found WET still noninferior at 60 weeks, with large within-group effects in both arms (d = 1.23 for WET and 1.38 for CPT) and a faster fall in depressive symptoms with CPT[9].

The second trial randomized 169 active-duty service members, nearly all Army personnel in Texas, to five weekly WET sessions or 12 twice-weekly CPT sessions. WET was again noninferior, with the largest difference 3.96 points and between-group effects from 0.06 to 0.22[2].

The third randomized 178 veterans at three VA medical centers to five to seven WET sessions of 45 to 60 minutes, each including 30 minutes of writing, or eight to fifteen 90-minute sessions of prolonged exposure with in vivo exposure between sessions. WET was noninferior at all assessments[3].

Dropout

Lower dropout is the most consistent difference between WET and the comparison treatments. In the first CPT trial, 6.4% of patients dropped out of WET and 39.7% out of CPT[1]. In the service members’ trial, 76.5% of those assigned to WET and 54.8% of those assigned to CPT completed all sessions[2]. In the trial against prolonged exposure, 12.5% dropped out of WET and 35.6% out of prolonged exposure[3]. For comparison, a meta-analysis of randomized trials of psychological therapies for PTSD put the pooled dropout rate at 16% and found higher dropout from therapies with a trauma focus[10].

Results outside the developers’ efficacy trials

A 2024 systematic review, co-authored by Sloan, identified 17 studies, seven of them randomized, including group, telehealth and translated versions. It reported large between-group effects except in the three studies with a trauma-focused comparison, where they were small (d = 0.01 to 0.31), and generally low dropout[11].

A pragmatic trial in primary care tested WET in routine conditions. Among 700 patients at federally qualified health centers and VA medical centers, WET as a first treatment did not differ significantly from a selective serotonin reuptake inhibitor after four months, but only 31.5% of patients assigned to WET completed all sessions. For patients who had not responded to an SSRI, adding WET produced a smaller reduction in symptoms than switching to venlafaxine[5].

Guideline status

The 2023 clinical practice guideline of the US Departments of Veterans Affairs and Defense suggests WET, with a weak recommendation, alongside Ehlers’ cognitive therapy for PTSD and present-centered therapy, while strongly recommending cognitive processing therapy, EMDR and prolonged exposure[4][12]. The guideline notes that WET had been covered by a strong recommendation in 2017 as a form of trauma-focused written narrative exposure, and was downgraded when treatments were assessed individually. It observes that only one of the WET trials it reviewed was conducted entirely in a military population and that all were conducted by the developers, which may limit generalizability because of potential allegiance bias. It also notes that WET might be more feasible where weekly sessions are hard to deliver, because it requires fewer and briefer sessions[4].

Limits of the evidence

The noninferiority trials show that WET is not substantially worse than the comparison treatments, not that it is better, and all were run by the developers, who receive royalties from the treatment manual[3][4]. Completion rates in a routine primary care trial were far lower than in the efficacy trials[5]. The evidence therefore supports WET as a shorter alternative within the trauma-focused group, a judgment that rests largely on research by its originators.

Sources12

Numbered in order of first citation.

  1. 1.Sloan, D. M., Marx, B. P., Lee, D. J., & Resick, P. A. (2018). A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: A randomized noninferiority clinical trial. JAMA Psychiatry, 75(3), 233–239. https://doi.org/10.1001/jamapsychiatry.2017.4249
  2. 2.Sloan, D. M., Marx, B. P., Resick, P. A., Young-McCaughan, S., Dondanville, K. A., Straud, C. L., Mintz, J., Litz, B. T., Peterson, A. L., & STRONG STAR Consortium (2022). Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: A randomized noninferiority trial. JAMA Network Open, 5(1), e2140911. https://doi.org/10.1001/jamanetworkopen.2021.40911
  3. 3.Sloan, D. M., Marx, B. P., Acierno, R., Messina, M., Muzzy, W., Gallagher, M. W., Litwack, S., & Sloan, C. (2023). Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 80(11), 1093–1100. https://doi.org/10.1001/jamapsychiatry.2023.2810
  4. 4.Department of Veterans Affairs and Department of Defense (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder (version 4.0). U.S. Department of Veterans Affairs and U.S. Department of Defense. www.healthquality.va.gov/guidelines/MH/ptsd/
  5. 5.Fortney, J. C., Kaysen, D. L., Engel, C. C., Cerimele, J. M., Nolan JP Jr, Chase, E., Blanchard, B. E., Hauge, S., Bechtel, J., Taylor, A., Acierno, R., Nagel, N., Sripada, R. K., Painter, J. T., DeBeer, B. B., Zimberoff, A., Bluett, E. J., Teo, A. R., Morland, L. A., … Heagerty, P. J. (2025). Pragmatic comparative effectiveness of primary care treatments for posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 82(12), 1203–1215. https://doi.org/10.1001/jamapsychiatry.2025.2962
  6. 6.Sloan, D. M., & Marx, B. P. (2019). Written exposure therapy for PTSD: A brief treatment approach for mental health professionals. American Psychological Association.
  7. 7.Sloan, D. M., Marx, B. P., Acierno, R., Messina, M., & Cole, T. A. (2021). Comparing written exposure therapy to Prolonged Exposure for the treatment of PTSD in a veteran sample: A non-inferiority randomized design. Contemporary Clinical Trials Communications, 22, 100764. https://doi.org/10.1016/j.conctc.2021.100764
  8. 8.Sloan, D. M., Marx, B. P., Bovin, M. J., Feinstein, B. A., & Gallagher, M. W. (2012). Written exposure as an intervention for PTSD: A randomized clinical trial with motor vehicle accident survivors. Behaviour Research and Therapy, 50(10), 627–635. https://doi.org/10.1016/j.brat.2012.07.001
  9. 9.Thompson-Hollands, J., Marx, B. P., Lee, D. J., Resick, P. A., & Sloan, D. M. (2018). Long-term treatment gains of a brief exposure-based treatment for PTSD. Depression and Anxiety, 35(10), 985–991. https://doi.org/10.1002/da.22825
  10. 10.Lewis, C., Roberts, N. P., Gibson, S., & Bisson, J. I. (2020). Dropout from psychological therapies for post-traumatic stress disorder (PTSD) in adults: systematic review and meta-analysis. European Journal of Psychotraumatology, 11(1). https://doi.org/10.1080/20008198.2019.1709709
  11. 11.DeJesus, C. R., Trendel, S. L., & Sloan, D. M. (2024). A systematic review of written exposure therapy for the treatment of posttraumatic stress symptoms. Psychological Trauma: Theory, Research, Practice, and Policy, 16(Suppl 3), S620–S626. https://doi.org/10.1037/tra0001659
  12. 12.Schnurr, P. P., Hamblen, J. L., Wolf, J., Coller, R., Collie, C., Fuller, M. A., Holtzheimer, P. E., Kelly, U., Lang, A. J., McGraw, K., Morganstein, J. C., Norman, S. B., Papke, K., Petrakis, I., Riggs, D., Sall, J. A., Shiner, B., Wiechers, I., & Kelber, M. S. (2024). The management of posttraumatic stress disorder and acute stress disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of Internal Medicine, 177(3), 363–374. https://doi.org/10.7326/M23-2757

Further reading

  • Sloan, D. M., Marx, B. P., Lee, D. J., & Resick, P. A. (2018). A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: A randomized noninferiority clinical trial. JAMA Psychiatry, 75(3), 233–239. https://doi.org/10.1001/jamapsychiatry.2017.4249
  • Sloan, D. M., Marx, B. P., Acierno, R., Messina, M., Muzzy, W., Gallagher, M. W., Litwack, S., & Sloan, C. (2023). Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 80(11), 1093–1100. https://doi.org/10.1001/jamapsychiatry.2023.2810

Cite this entry

  • APA 7

    Psych Dictionary. (2026, October 19). Written exposure therapy (WET). In Psych Dictionary. https://www.psychdictionary.com/therapies/written-exposure-therapy

  • MLA 9

    “Written Exposure Therapy (WET).” Psych Dictionary, 19 Oct. 2026, www.psychdictionary.com/therapies/written-exposure-therapy.

Written by Editorial team. First published October 19, 2026. Editorial standards

Educational reference material. Nothing on this site is a diagnosis, a treatment recommendation or a substitute for care from a qualified clinician.